650 related articles for article (PubMed ID: 17292061)
1. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
Koo OM; Rubinstein I; Onyuksel H
Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
[TBL] [Abstract][Full Text] [Related]
2. Camptothecin in sterically stabilized phospholipid nano-micelles: a novel solvent pH change solubilization method.
Koo OM; Rubinstein I; Onyuksel H
J Nanosci Nanotechnol; 2006; 6(9-10):2996-3000. PubMed ID: 17048510
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs.
Sezgin Z; Yüksel N; Baykara T
Eur J Pharm Biopharm; 2006 Nov; 64(3):261-8. PubMed ID: 16884896
[TBL] [Abstract][Full Text] [Related]
4. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
5. Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability.
Watanabe M; Kawano K; Yokoyama M; Opanasopit P; Okano T; Maitani Y
Int J Pharm; 2006 Feb; 308(1-2):183-9. PubMed ID: 16324807
[TBL] [Abstract][Full Text] [Related]
6. Biologically active camptothecin derivatives for incorporation into liposome bilayers and lipid emulsions.
Lundberg BB
Anticancer Drug Des; 1998 Jul; 13(5):453-61. PubMed ID: 9702210
[TBL] [Abstract][Full Text] [Related]
7. Preparation and antitumor study of camptothecin nanocrystals.
Zhang H; Hollis CP; Zhang Q; Li T
Int J Pharm; 2011 Aug; 415(1-2):293-300. PubMed ID: 21679755
[TBL] [Abstract][Full Text] [Related]
8. SDS-aided immobilization and controlled release of camptothecin from agarose hydrogel.
Liu J; Li L
Eur J Pharm Sci; 2005 Jun; 25(2-3):237-44. PubMed ID: 15911219
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of camptothecin into N-phthaloyl chitosan-g-mPEG self-assembly micellar system.
Opanasopit P; Ngawhirunpat T; Chaidedgumjorn A; Rojanarata T; Apirakaramwong A; Phongying S; Choochottiros C; Chirachanchai S
Eur J Pharm Biopharm; 2006 Nov; 64(3):269-76. PubMed ID: 16870407
[TBL] [Abstract][Full Text] [Related]
10. In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin.
Watanabe M; Kawano K; Toma K; Hattori Y; Maitani Y
J Control Release; 2008 May; 127(3):231-8. PubMed ID: 18384903
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.
Huang ZR; Hua SC; Yang YL; Fang JY
Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178
[TBL] [Abstract][Full Text] [Related]
12. Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101.
Svenson S; Wolfgang M; Hwang J; Ryan J; Eliasof S
J Control Release; 2011 Jul; 153(1):49-55. PubMed ID: 21406204
[TBL] [Abstract][Full Text] [Related]
13. Fabrication of nanomicelle with enhanced solubility and stability of camptothecin based on alpha,beta-poly[(N-carboxybutyl)-L-aspartamide]-camptothecin conjugate.
Fan N; Duan K; Wang C; Liu S; Luo S; Yu J; Huang J; Li Y; Wang D
Colloids Surf B Biointerfaces; 2010 Feb; 75(2):543-9. PubMed ID: 19846282
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery.
Cirpanli Y; Bilensoy E; Lale Doğan A; Caliş S
Eur J Pharm Biopharm; 2009 Sep; 73(1):82-9. PubMed ID: 19442723
[TBL] [Abstract][Full Text] [Related]
15. Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin.
Mu L; Elbayoumi TA; Torchilin VP
Int J Pharm; 2005 Dec; 306(1-2):142-9. PubMed ID: 16242875
[TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG).
Chandran T; Katragadda U; Teng Q; Tan C
Int J Pharm; 2010 Jun; 392(1-2):170-7. PubMed ID: 20363305
[TBL] [Abstract][Full Text] [Related]
17. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
[TBL] [Abstract][Full Text] [Related]
18. Preparation and cytotoxic activity of hydroxycamptothecin nanosuspensions.
Zhao YX; Hua HY; Chang M; Liu WJ; Zhao Y; Liu HM
Int J Pharm; 2010 Jun; 392(1-2):64-71. PubMed ID: 20302926
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin.
Gao Y; Li LB; Zhai G
Colloids Surf B Biointerfaces; 2008 Jul; 64(2):194-9. PubMed ID: 18325744
[TBL] [Abstract][Full Text] [Related]
20. Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs.
Krishnadas A; Rubinstein I; Onyüksel H
Pharm Res; 2003 Feb; 20(2):297-302. PubMed ID: 12636171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
